Baylor Scott & White Health, Temple, TX
Pruthali Kulkarni , Laurel Copeland , James Andy Hall , Jyothi Dodlapati
Background: Multiple myeloma (MM) accounts for 1-2% of cancers worldwide. MM and monoclonal gammopathy of unknown significance (MGUS) are associated with Agent Orange exposure (AO) in Vietnam war veterans. Studies show poor outcomes in AO-exposed patients developing MM. No study has evaluated AO exposure and adverse cytogenetics in patients with MM. Methods: We reviewed patients with MGUS and/or MM in the Central Texas Veterans Health Administration system in 2010-2015 to evaluate AO exposure, adverse cytogenetics, transformation from MM to MGUS, and overall survival (OS). Inclusion criteria were active-duty military when AO was used (1961-1971). Presence of 17p13, t(4;14), t(14;16), t(14;20), or Gain 1q by FISH defined high-risk cytogenetics. Poor prognosis per serum free kappa/lambda ratio was defined as < .03 or > 32 K/L (high-risk). Regulatory review approval was obtained. Cox survival models generated hazard rate ratios and their 95% confidence intervals (HR) for AO status (AO, non-AO, undetermined), age, race/ethnicity, transformation, and FISH data. Results: Among 129 veterans, 30% were Black and 12% Hispanic (mean age 74.0 years, SD 6.9, range 59-97). MGUS was diagnosed in 44%, MM 74%, and transformation 19%. FISH abnormalities were rare thus AO association cannot be definitively stated; see table. A subsample with known AO and K/L (n = 81) showed no association: 69% high-risk had AO vs 76% moderate-risk; chi2 = 0.54; p = .46. In the adjusted model, Hispanic patients (HR = 3.3; 1.2-9.1) and those with high-risk cytogenetics (HR = 6.0; 1.1-34.1) had higher mortality; AO was unrelated. Conclusions: Although preliminary analyses find no associations of AO and transformation with OS, ethnicity and FISH abnormality associations are intriguing. Chart review is 50% complete. The paucity of cytogenetics data begs further examination, and continued study is merited to fully recognize what predisposes MM development following AO exposure.
Vietnam Veterans | AO-exposed (n = 72) | Non-AO (n = 22) | Undetermined AO (n = 33) |
---|---|---|---|
Hispanic | 11 (16%) | 0 (0%) | 4 (13%) |
MGUS | 22 (31%) | 8 (36%) | 3 (9%) |
MM | 36 (50%) | 8 (36%) | 27 (82%) |
MGUS+MM | 14 (19%) | 6 (27%) | 3 (9%) |
High-risk cytogenetics | 3 (4%) | 1 (5%) | 2 (6%) |
High-risk K/L ratio | 20 (28%) | 9 (41%) | 7 (21%) |
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2022 ASCO Annual Meeting
First Author: Lawrence Liu
2024 ASCO Annual Meeting
First Author: Ram Prakash Thirugnanasambandam
2024 ASCO Annual Meeting
First Author: Zoe McKinnell
2024 ASCO Annual Meeting
First Author: Mei Wang